http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101699378-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-314 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7032 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-45 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7032 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-45 |
| filingDate | 2015-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101699378-B1 |
| titleOfInvention | Composition comprising extract of Rhododendron brachycarpum or megastigmane glucosides isolated therefrom for preventing or treating sepsis |
| abstract | The present invention relates to a composition for preventing or treating septicemia, which contains a moxa agar extract or a megastigue main glycoside isolated therefrom, wherein the composition is effective for inhibiting the expression of HMGB1 (high mobility group box 1) in vascular endothelial cells Can be easily used as a health functional food for preventing or treating sepsis or for preventing or treating sepsis. |
| priorityDate | 2015-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 78.